Key result
The α2δ subunit regulates Ca²⁺ signaling gain, with dysfunction linked to complex chronic diseases.
Design
Theoretical framework
α2δ-targeted strategies merit preclinical exploration in chronic disease; this Level 5 model leaves open human validation and clinical translation.
This paper presents a novel theoretical framework for understanding Ca²⁺ signaling through an analogy with the seven-layer OSI (Open Systems Interconnection) model from computer networking. We identify seven key regulators/families of intracellular Ca²⁺ (VGCC+α2δ, IP3R, RyR, STIM/Orai, NCX, PMCA, mitochondrial uniporter) and map them onto the functional layers of a communication model. This approach reveals that traditionally separate regulators are in fact parts of a single, hierarchically organized information system. The α2δ subunit plays the central role as the “Layer 7 (Program-Access/Gain-Control) position” (analogous to the OSI application layer), functioning as a gain controller in critical neural and autonomic circuits. We propose that this organizational logic is key to understanding systemic dysregulation in complex chronic diseases. The framework is integrated with the NOAH6 (Neuro-Organizational Architecture of Homeostasis) model, which redefines pathology as a loss of access to regulatory programs rather than a local failure. The model generates testable hypotheses and offers new strategies for developing targeted therapies. A Single-Sentence Summary This paper presents a conceptually powerful and original systems-theoretical framework that reinterprets Ca²⁺ signaling through a strict OSI model hierarchy, identifying the α2δ subunit as the “Layer 7 (Program-Access/Gain-Control) position” gain-controller whose dysfunction explains the convergent pathophysiology of complex chronic diseases, generating falsifiable hypotheses for a new class of hierarchical, reset-based therapies.
No takes yet. Share an insight, caveat, or question.
Zakir Causevic (2025) studied this question. The α2δ subunit functions as a central gain-controller in Ca²⁺ signaling, with its dysfunction linked to the pathophysiology of complex chronic diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: